Xtant Medical Holdings, Inc. (XTNT)

0.713 +0.03 (+4.55%) USD  |  NYAM  |  Jan 12, 16:00
0.713 0.00 (0.00%) After-Hours: 17:23
More

Xtant Medical Holdings Research and Development Expense (Per Share Quarterly)

Research and Development Expense (Per Share Quarterly) Chart

View Research and Development Expense (Per Share Quarterly) for XTNT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Per Share Quarterly) Range, Past 5 Years

View Research and Development Expense (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Per Share Quarterly) Benchmarks

View Research and Development Expense (Per Share Quarterly) Benchmarks
Start Trial
Sensus Healthcare, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade
InfuSystem Holdings, Inc. --
VolitionRX Ltd. Upgrade
Catheter Precision, Inc. Upgrade